[Antibiotic prophylaxis in transrectal prostate biopsy]

Daniel Muñoz Vélez1, Antoni Vicens Vicens, Mariano Ozonas Moragues

  • 1Servicio de Urología, Hospital Universitario Son Dureta, Palma de Mallorca, España. dr.munoz.velez@gmail.com

Actas Urologicas Espanolas
|November 11, 2009
PubMed
Abstract

Insights

Prophylactic antibiotics significantly reduce genitourinary infections following prostate biopsies. Oral, single-dose, or short-term antibiotic prophylaxis is recommended based on common bacterial sensitivities, though further research on enemas is needed.

Area of Science:

  • Urology
  • Infectious Diseases

Context:

  • Transrectal ultrasound-guided prostate biopsies carry a risk of genitourinary infections (GUI).
  • Current antibiotic prophylaxis protocols vary significantly between medical centers.
  • There is a lack of established guidelines for antibiotic prophylaxis before prostate biopsies.

Purpose:

  • To review and synthesize existing literature on antibiotic prophylaxis protocols for transrectal ultrasound-guided prostate biopsies.
  • To evaluate the efficacy of antibiotic prophylaxis in reducing GUI incidence.

Summary:

  • A review of five articles indicated that antibiotic prophylaxis is associated with lower rates of bacteriuria and infectious complications compared to placebo.
  • Escherichia coli is the most frequent causative agent of GUI.
  • Oral quinolones are commonly used for prophylaxis. Studies found no significant differences between oral versus parenteral administration or between single-dose/short-term versus longer courses.

Impact:

  • Prophylactic antibiotic administration is beneficial in preventing GUIs post-prostate biopsy.
  • Optimal timing and choice of oral antibiotics (single or short-term course) should consider microbial sensitivities.
  • Further research is required to ascertain the role of pre-biopsy enemas in mitigating infectious complications.